HCVerso3: An Open-Label, Phase IIb Study of Faldaprevir and Deleobuvir with Ribavirin in Hepatitis C Virus Genotype-1b-Infected Patients with Cirrhosis and Moderate Hepatic Impairment

This study evaluated the interferon-free, oral combination of deleobuvir (non-nucleoside HCV NS5-RNA-polymerase inhibitor) and faldaprevir (HCV NS3/4A-protease inhibitor) with ribavirin in patients with HCV genotype-1b and moderate (Child-Pugh B [CPB], n = 17) or mild hepatic impairment (Child-Pugh...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarrazin, Christoph, Manns, Michael, Calleja, Jose Luis, Garcia-Samaniego, Javier, Forns, Xavier, Kaste, Renee, Bai, Xiaofei, Wu, Jing, Stern, Jerry O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193411/
https://www.ncbi.nlm.nih.gov/pubmed/28030579
http://dx.doi.org/10.1371/journal.pone.0168544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193411/
https://www.ncbi.nlm.nih.gov/pubmed/28030579
http://dx.doi.org/10.1371/journal.pone.0168544

Ejemplares similares